SynAgile
SynAgile™ is dedicated to transforming the treatment of L-DOPA-responsive motor and non-motor complications in patients with Parkinson's disease. Our novel drugs and routes of administration are designed to enable patients to achieve stable plasma L-DOPA concentrations, and to provide convenient, continuous dopaminergic stimulation.
Industries
biotechnology
health-care
health-diagnostics
Nr. of Employees
small (1-50)
SynAgile
Piedmont, California, United States, North America
Products
DopaFuse
An infusion therapy designed to stabilize L-DOPA levels in patients with Parkinson’s disease.
DopaFuse
An infusion therapy designed to stabilize L-DOPA levels in patients with Parkinson’s disease.